ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0968

Clinical and Histopathologic Characteristics of Medical Kidney Biopsies from Incarcerated Persons in the Southwestern United States

Session Information

Category: Diversity and Equity in Kidney Health

  • 900 Diversity and Equity in Kidney Health

Authors

  • Lin, Mercury Y., Cedars-Sinai, Los Angeles, California, United States
  • Hou, Jean, Cedars-Sinai, Los Angeles, California, United States
  • Haas, Mark, Cedars-Sinai, Los Angeles, California, United States
  • Yamashita, Michifumi, Cedars-Sinai, Los Angeles, California, United States
  • Choung, Hae Yoon Grace, Cedars-Sinai, Los Angeles, California, United States
  • Nast, Cynthia C., Cedars-Sinai, Los Angeles, California, United States
Background

The United States of America has the largest incarcerated population. Yet, little literature exisits in study of inmate kidney biopsies.

Methods

An IRB approved study retrospectively identified inmate kidney biopsies from 2009-2025. Demographics, clinical history and pathologic parameters were analyzed.

Results

117 kidney inmate biopsies (from 116 patients) were identified from 25 clinical sites primarily in the Southwestern US. All were native kidney biopsies. Patients had mean age of 46 (range 21-76). 114 were cis-male, 1 was cis-female and 1 was trans-female. Ethnicities were 40 Hispanic, 30 African-American, 9 White, 2 American Indian/Alaskan Native, 1 Asian-American and 34 unspecified. 64 had hypertension and 22 were diabetic. 41 had chronic viral infection [most common were HCV (in 30) and HIV (in 6)]. 17 had illicit substance use [most common were opioids (in 6) and methamphetamines (in 4)]. Only 2 had prior kidney biopsies (excluding 1 with rebiopsy due to inadequacy). Indications for biopsy include 91 with renal insufficiency (81 for AKI, 7 for CKD, 3 for acute-on-chronic renal failure), 85 with proteinuria (38 with nephrotic range proteinuria) and 39 with hematuria (5 with gross hematuria). Of biopsies, 104 were optimal (cortex present in LM, IF and EM specimens), 12 were suboptimal (absence of cortex in at least 1 specimen) and 1 was inadequate for evaluation. The primary diagnoses were 30 with FSGS (including 5 with "collapsing" FSGS), 21 with IgAN and 14 with diabetic nephropathy, 12 with arterial nephrosclerosis, 9 with membranous nephropathy (2 PLA2R+, 7 PLA2R-), 9 with ATN, 6 with acute interstitial nephritis, 6 with amyloidosis (4 AA amyloidosis, 2 AL amyloidosis), 5 with infection-related GN and 5 with lupus nephritis. For IF/TA, 34 showed minimal (<10%), 45 showed mild (10-25%), 35 showed moderate (26-50%), 9 showed severe (>50%) and 4 were undetermined.

Conclusion

The most common indication for inmate kidney biopsy was renal insufficiency, closely followed by proteinuria. Almost all inmates obtained their index biopsy while incarcerated and the most frequent diagnoses were FSGS, IgAN and diabetic nephropathy. Most biopsies showed minimal or mild IF/TA. There was a low biopsy inadequacy rate (<1%). Limitation of this study included nearly all cis-male cohort, no transplant biopsies and no clinical follow-up data.